Beigene, Ltd. (BGNE) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Beigene, Ltd.

CIK: 1651308 Ticker: BGNE

View differences made from one to another to evaluate Beigene, Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Beigene, Ltd..


Assess how Beigene, Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Beigene, Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Beigene, Ltd. provided additional information to their SEC Filing as exhibits

Ticker: BGNE
CIK: 1651308
Form Type: 8-K Corporate News
Accession Number: 0001651308-19-000092
Submitted to the SEC: Wed Oct 02 2019 4:16:35 PM EST
Accepted by the SEC: Wed Oct 02 2019
Period: Monday, September 30, 2019
Industry: Pharmaceutical Preparations
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: